Artemis Medicare Services Ltd (AMSL), founded in 2004 by Apollo Tyres Group promoters, operates a 541-bed multi-specialty tertiary hospital in Gurgaon with key strengths in orthopaedics, oncology, cardiovascular, neurosciences, and minimally invasive surgery. AMSL is accredited by NABH and JCI, and has diversified through models including Artemis Daffodil, Artemis Lite, Artemis Cardiac Care, and Artemis Solace. Presenting below its Q1 FY26 Earnings Results.
Q1 FY26 Earnings Results
- Revenue: ₹250 crore, up 15.21% year-on-year (YoY) from ₹217 crore in Q1 FY25.
- Total Expenses: ₹227 crore, up 14.07% YoY from ₹199 crore.
- Consolidated Net Profit (PAT): ₹21 crore, up 23.53% from ₹17 crore in the same quarter last year.
- Earnings Per Share (EPS): ₹1.54, up 24.19% from ₹1.24 YoY.
Operational & Strategic Update
- Steady Revenue Growth: Revenues increased by more than 15% on expanded services, specialty care, and diversified healthcare models.
- Disciplined Expense Management: Expenses rose 14%, slightly slower than revenue growth, contributing to margin expansion.
- Strong Profit Growth: Net profit and EPS rose by approximately 24%, reflecting operational efficiencies and strengthened healthcare offerings.
- Market Position: AMSL maintains a strong presence in NCR’s premium healthcare market, known for clinical excellence and international accreditations.
- Strategic Focus: The company is growing specialty and tertiary care, broadening physical and digital outreach, and investing in innovative patient care.
Corporate Developments in Q1 FY26 Earnings
Q1 FY26 results highlight Artemis Medicare’s profitable growth, reflecting disciplined operations and strategic specialty expansion.
Looking Ahead
AMSL aims to enhance value by further expanding specialties, adopting new healthcare models, and focusing on patient-centric operational excellence for sustained long-term growth.
Explore the company’s past earnings and latest concall transcripts, click here to visit the AlphaStreet India News Channel.